Qiming Venture Partners

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

Zhang Ao

Executive Director

Artavazd Arumov Ph.D

Principal

Ryan Baker

CFO

Cyrus Chan

Associate

Nan Chen

Principal

David Chu

Partner

Isaac Ciechanover

Partner

Phil DiGiacomo

Principal

Anna French

Managing Partner

Yuxin Fu

Vice President

Jinda Gao

Principal

Kuantai Yeh

Partner

Robert Headley

Partner

Maykin Ho

Venture Partner

William Hu

Managing Partner

Duane Kuang

Co-Founder and Managing Partner

Nisa Leung

Managing Partner

Dingzheng Li

Vice President

Bin Liu

Vice President

Jing Liu

Vice President

Chang Liu

Associate

Biao Lu

Associate

Shuo Mao

Principal

Will McConnell

Principal

Gary Rieschel

Managing Partner

James Shen

Venture Partner

Motao Sun

Vice President

Amy Tang

Venture Partner

Yi Tang

Principal

Shiyu Wang

Partner

Rachel Wang

Venture Partner

James Wang

Venture Partner

Xu Gillian

RMB funds CFO

Peter (Ming) Yin

Principal, Cleantech

Janet Yu

Partner

Oscar Zhang

Principal

Zhiyuan Zhou

Associate

Alex Zhou

Managing Partner

Yafeng Zhou

Associate

Zhifeng Zhou

Managing Partner

Phillip DiGiacomo Ph.D

Principal

Jing-Shan Hu Ph.D

Venture Partner of Healthcare

Past deals in Technical Support

CSR Biotech

Series A in 2024
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

CSR Biotech

Series A in 2023
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

moodytiger

Convertible Note in 2023
moodytiger is a technical athletic apparel brand for children from age of 4 to 16. Today, kids from more than 100 countries, from United States to Australia, from Singapore to Hong Kong, have worn moodytiger outfits in their wonderful active adventure! Born to redefine kids’ athlectic wear from day one, our products are specially tailored for children with perfect combination of high-tech fabrics and fashion-forward designs, and functionally suited for multiple sports, including tennis, skiing, skating, swimming, outdoor, and everyday active living. As one of the fastest growing and most innovative brands in the category, we thrive to be the new industry benchmark setter with what we do.

Vongi

Series B in 2023
Vongi offers medical solution design, product design and RandD, pilot test transformation, clinical research, registration services, and commercial operations for companies that need digital therapy, real-world research, and digital therapy CDMO and process services. For inquiries, their email address, telephone number, and physical address are available on their website.

CSR Biotech

Seed Round in 2022
CSR Biotech is a biological research company that specializes in the development and manufacturing of super-resolution imaging instruments for living cells. The company focuses on creating and deploying advanced imaging technology, offering a range of services including customized cell sample generation, high-throughput detection, imaging studies, and image post-processing with quantitative analysis. By providing these specialized tools and services, CSR Biotech aims to support bio researchers in discovering new disease biomarkers and innovative drug targets, thereby contributing to advancements in the field of biotechnology.

Chatail

Series B in 2022
Chatail is a company that specializes in developing sales software tailored for live commerce. It provides a comprehensive live broadcast sales mechanism for businesses, facilitating the effective use of live video to enhance sales efforts. The platform is designed to help brands initiate and optimize their live video commerce strategies, allowing sales associates and call center representatives to engage customers interactively and drive traffic to physical retail locations. Key features of Chatail's offerings include cross-store linking, enterprise micro synergy, and various sales tools that enhance the overall sales process without requiring live broadcasts. Through its innovative approach, Chatail aims to transform the way businesses leverage live video for sales growth.

moodytiger

Series B in 2021
moodytiger is a technical athletic apparel brand for children from age of 4 to 16. Today, kids from more than 100 countries, from United States to Australia, from Singapore to Hong Kong, have worn moodytiger outfits in their wonderful active adventure! Born to redefine kids’ athlectic wear from day one, our products are specially tailored for children with perfect combination of high-tech fabrics and fashion-forward designs, and functionally suited for multiple sports, including tennis, skiing, skating, swimming, outdoor, and everyday active living. As one of the fastest growing and most innovative brands in the category, we thrive to be the new industry benchmark setter with what we do.

Vongi

Series B in 2019
Vongi offers medical solution design, product design and RandD, pilot test transformation, clinical research, registration services, and commercial operations for companies that need digital therapy, real-world research, and digital therapy CDMO and process services. For inquiries, their email address, telephone number, and physical address are available on their website.

Vongi

Series A in 2017
Vongi offers medical solution design, product design and RandD, pilot test transformation, clinical research, registration services, and commercial operations for companies that need digital therapy, real-world research, and digital therapy CDMO and process services. For inquiries, their email address, telephone number, and physical address are available on their website.

CooTek

Series D in 2017
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

CooTek

Series D in 2016
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

CooTek

Series C in 2014
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

CooTek

Series B in 2012
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

CooTek

Series A in 2012
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

Fangtek

Series C in 2006
Shanghai Fangtek Electronics Co., Ltd. is a specialized integrated circuit design company established in 2003 and based in Shanghai, China, with an additional office in Shenzhen. The company focuses on the design, development, and marketing of analog and mixed-signal power management integrated circuits tailored for communication, computing, and consumer markets. Fangtek's product offerings include audio power amplifiers, LED drivers, SIM card controllers, analog switches, reset integrated circuits, charger protection devices, and voltage regulators. These products are utilized across various applications, including mobile phones, MP3/4 players, GPS devices, mini sound boxes, and other consumer electronics. By leveraging advanced mixed-signal design techniques and power device technologies, Fangtek aims to deliver innovative and cost-effective solutions that meet the demands of voice, light, and power management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.